Exhibit 10.64

 

September 18, 2003

By Federal Express

 

Monika Henninger, Ph.D.

Customer Relations & Projects

Boehringer Ingelheim Austria, GmbH

Dr. Boehringer-Gasse 5-11

A-1121 Vienna

Austria

 

Re:                               Amendment No. 2 to Data Transfer, Clinical
Trial And Market Supply Agreement January 27, 2000

 

Dear Dr. Henninger;

 

As you know, InterMune, Inc. (“InterMune”) and Boehringer Ingelheim Austria GmbH
(“BI Austria”) are parties to that certain Data Transfer, Clinical Trial And
Market Supply Agreement effective January 27, 2000, as amended June 19, 2002
(the “Agreement”).  The parties hereby agree to amend the Agreement as set forth
below, effective as of the date of this letter.  Any capitalized term used in
this letter and not otherwise defined will have the same meaning as set forth in
the Agreement.

 

1.               Section [*] of the Agreement is hereby replaced and superseded
in its entirety by the following:

 

“[*] BI Austria shall [*] for the [*] except for the [*] BI Austria shall [*]
for the [*] except for the [*] any third party without [*] prior written
consent.  InterMune shall [*] and from the [*] for the term of this Agreement,
subject to [*]”

 

2.               Section [*] of the Agreement [*] is hereby replaced and
superseded in its entirety by the following:

 

“InterMune [*] for the [*] of any [*] the development of [*] where it [*] then
prior to [*] shall notify [*] in writing.  If [*] after any such notice from [*]
upon which [*] would be willing to [*] would be willing to [*] then the Parties
shall [*] If the [*] during such time period, then [*] with respect to the [*]”

 

Except as set forth above, all terms and conditions of the Agreement will remain
in full force and effect.

 

Please acknowledge your agreement to the above by having both enclosed copies of
this letter by authorized BI Austria representative where indicated below, and
returning one original to the attention of Gloria Lopez, Contracts
Administrator, at InterMune.  We would be happy to proceed based on receipt of a
facsimile copy while awaiting the original.

 

 

Sincerely,

 

/s/ Peter Van Vlasselaer

 

 

Peter Van Vlasselaer, Ph.D.

Senior Vice President of Technical Operations

 

1

--------------------------------------------------------------------------------

 

Acknowledged and Agreed:

 

Boehringer Ingelheim Austria, GmbH

 

By:

/s/ R. Kurt Konopiizwy

 

Name:

R. Kurt Konopiizwy

 

Title:

Head Operations

 

Date:

25.9.2003

 

 

 

 

By:

/s/ M. Henninger

 

Name:

Dr. Monika Henninger

 

Title:

Customer Relations & Projets

 

Date:

23.Sept.03

 

 

2

--------------------------------------------------------------------------------